TrialJournal for immunotherapy of cancer2026

Ivonescimab plus chemotherapy as first-line treatment for advanced thymic carcinoma: preliminary results of a phase II trial with biomarker analyses.

Jie-Tao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.